PhIMeninInhibitorSNDX-5613ComboW/Daunorubicin&CytarabineNewDxPtsW/AcuteMyeloidLeukemia&NPM1
Kiran Naqvi
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 20 of 275 Results
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Tahseen Mozaffar
- OPEN TO ACCRUAL
ARGX-113-2011
Tahseen Mozaffar
- OPEN TO ACCRUAL
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b)
Judith Chung
- OPEN TO ACCRUAL
Alopecia Areata: Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Severe A
Natasha Mesinkovska
- OPEN TO ACCRUAL
PhII NanO2TM Combo w/Rad&Temozolomide Pa w/NewlyDia GlioblsdtomaMultiforme: RESTORE
Xiao-Tang Kong
- OPEN TO ACCRUAL
PhIII TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy Tx of Upper Tract Urothelial Ca
Edward Uchio
- OPEN TO ACCRUAL
NEO-RT Trial:PhIII RandomNeoadjChemo Excision&Obs Vs Chemoradiothe forEarly RectalCa
Jason Zell
- OPEN TO ACCRUAL
PhII Daratumumab Selinexor Velcade Dexamethasone HighRisk New Dx MultipleMyeloma
Lisa Xingguang Lee
- OPEN TO ACCRUAL
PhIb/II Open-Label Study Disitamab Vedotin Monother or inCombination w/OtherAntica Therapies SolidTu
Farshid Dayyani
- OPEN TO ACCRUAL
OptimicePCR:DeescalationThe EarlStageTNBCPa whoAchievePCR AfterNeoadj Chemothe w/Checkpoint InhibThe
Ritesh Parajuli
- OPEN TO ACCRUAL
EarlyPh&PhII TrialEvaluateGangliosideMonosialicAcid PreventPaclitaxelAssociatedNeuropathy
Ritesh Parajuli
- OPEN TO ACCRUAL
Ph II/III of Calaspargase Pegol for Tx of Adults Aged 22 to >65 Years w/ New Diagnose Ph- ALL
Deepa Jeyakumar
- OPEN TO ACCRUAL
Ph I/II Peposertib in Combo w/Hypofractionated Radiotherapy for Tx of Adv Pancreatic Adenocarcinoma
Farshid Dayyani
- OPEN TO ACCRUAL
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leu
Mahtab Jafari
- OPEN TO ACCRUAL
Double-Blind use of Staccato Alprazolam for participants with prolonged seizures
Lilit Mnatsakanyan
- OPEN TO ACCRUAL
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in participants with IPF
Huawei Dong
- OPEN TO ACCRUAL
Regeneron AA Multicenter (Dupilumab)
Natasha Mesinkovska
- OPEN TO ACCRUAL
A Study of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
Huawei Dong
- OPEN TO ACCRUAL
Prospective, Multi-Center, Randomized, Sham-Controlled Clinical Trial for Heart Failure
Antonio Frangieh
- OPEN TO ACCRUAL